[
  {
    "ts": "2025-09-22T21:31:02+00:00",
    "headline": "Piper Sandler Reiterates Its ‘Overweight’ Rating on AbbVie Inc. (ABBV) with a $231 PT",
    "summary": "AbbVie Inc. (NYSE:ABBV) is one of the 15 Best Stocks to Invest in for Financial Stability. On September 12, 2025, Piper Sandler reiterated its ‘Overweight’ rating on AbbVie Inc. (NYSE:ABBV) with a $231 price target. This comes after the company settled with abbreviated New Drug Application (ANDA) filers over Rinvoq. The agreement delays generic entry […]",
    "url": "https://finance.yahoo.com/news/piper-sandler-reiterates-overweight-rating-213102596.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "dd6435d8-84d9-3255-a888-bc448edb760b",
      "content": {
        "id": "dd6435d8-84d9-3255-a888-bc448edb760b",
        "contentType": "STORY",
        "title": "Piper Sandler Reiterates Its ‘Overweight’ Rating on AbbVie Inc. (ABBV) with a $231 PT",
        "description": "",
        "summary": "AbbVie Inc. (NYSE:ABBV) is one of the 15 Best Stocks to Invest in for Financial Stability. On September 12, 2025, Piper Sandler reiterated its ‘Overweight’ rating on AbbVie Inc. (NYSE:ABBV) with a $231 price target. This comes after the company settled with abbreviated New Drug Application (ANDA) filers over Rinvoq. The agreement delays generic entry […]",
        "pubDate": "2025-09-22T21:31:02Z",
        "displayTime": "2025-09-22T21:31:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/e1fa6773f5ef392577533056edd13e16",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Piper Sandler Reiterates Its ‘Overweight’ Rating on AbbVie Inc. (ABBV) with a $231 PT",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NYUC3muJx2iE7TvpUp8AhA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/e1fa6773f5ef392577533056edd13e16.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7Aq5oYQ0ynjMTw_jcOpY9g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/e1fa6773f5ef392577533056edd13e16.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/piper-sandler-reiterates-overweight-rating-213102596.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/piper-sandler-reiterates-overweight-rating-213102596.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-22T15:13:08+00:00",
    "headline": "What Is One of the Best Pharmaceutical Stocks to Buy Right Now?",
    "summary": "There aren't many companies in the industry that offer an excellent combination of growth and income.",
    "url": "https://www.fool.com/investing/2025/09/22/best-pharmaceutical-stocks-to-buy-now/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "d4338c85-d7af-33a8-a870-950cd5c689ed",
      "content": {
        "id": "d4338c85-d7af-33a8-a870-950cd5c689ed",
        "contentType": "STORY",
        "title": "What Is One of the Best Pharmaceutical Stocks to Buy Right Now?",
        "description": "",
        "summary": "There aren't many companies in the industry that offer an excellent combination of growth and income.",
        "pubDate": "2025-09-22T15:13:08Z",
        "displayTime": "2025-09-22T15:13:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/fe2cf4fa29b0e76013c6587b37e33d3f",
          "originalWidth": 1400,
          "originalHeight": 935,
          "caption": "Person checking shelves in a pharmacy.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eatslnb6WpfIlrAfG98jLw--~B/aD05MzU7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/fe2cf4fa29b0e76013c6587b37e33d3f.cf.webp",
              "width": 1400,
              "height": 935,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/x4o8B465cnEjO8f92w8Mgw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/fe2cf4fa29b0e76013c6587b37e33d3f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/09/22/best-pharmaceutical-stocks-to-buy-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/one-best-pharmaceutical-stocks-buy-151308332.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-22T08:46:00+00:00",
    "headline": "Forever Dividend Stocks: 3 Income Stocks I Never Plan to Sell",
    "summary": "Never say never? Maybe not with these great dividend stocks.",
    "url": "https://www.fool.com/investing/2025/09/22/forever-dividend-stocks-3-income-stocks-i-never-pl/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "ccfd2d22-3cdb-3e70-baa5-390dcca2fbc5",
      "content": {
        "id": "ccfd2d22-3cdb-3e70-baa5-390dcca2fbc5",
        "contentType": "STORY",
        "title": "Forever Dividend Stocks: 3 Income Stocks I Never Plan to Sell",
        "description": "",
        "summary": "Never say never? Maybe not with these great dividend stocks.",
        "pubDate": "2025-09-22T08:46:00Z",
        "displayTime": "2025-09-22T08:46:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/d733629f4069b264147d956cf1f2ae48",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A person holding hands behind head while sitting in front of a laptop.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5s3QPXuS_rNr4UkELpor8g--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/d733629f4069b264147d956cf1f2ae48.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EuNvAaXIFx9PcJDNckHXZA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/d733629f4069b264147d956cf1f2ae48.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/09/22/forever-dividend-stocks-3-income-stocks-i-never-pl/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/forever-dividend-stocks-3-income-084600272.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "BIP"
            },
            {
              "symbol": "O"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]